Evidence map›Paper›PMID 15821902›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2005

Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.

Eva-Maria D Nielsen, Lars Hansen, Trine Stissing, Keiko Yanagisawa, Knut Borch-Johnsen, Pernille Poulsen, Allan Vaag, Torben Hansen, Oluf Pedersen

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Cycling through metabolism.EMBO molecular medicine · 2010
    Review
  3. Article
  4. Is imprinting in printing or in press?Journal of molecular medicine (Berlin, Germany) · 2005
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eva-Maria D NielsenSteno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark.
Lars Hansen
Trine Stissing
Keiko Yanagisawa
Knut Borch-Johnsen
Pernille Poulsen
Allan Vaag
Torben Hansen
Oluf Pedersen
Steno Diabetes Center · DKAarhus University · DKNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CDK4 is involved in the regulation of body weight, pancreatic beta-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in beta-cell proliferation and is involved in the pathogenesis of the Beckwith-Wiedemann syndrome, a disorder characterized by neonatal hyperinsulinaemic hypoglycaemia and pre- and post-natal overgrowth. The aim of this study was to investigate if variations in the proximal promoter and the coding region of the CDKN1C and CDK4 genes are associated with type 2 diabetes or changes in related quantitative phenotypes among glucose-tolerant subjects. Mutation analyses of the two genes in 62 type 2 diabetic patients resulted in the discovery of seven variants of CDKN1C and two variants of CDK4. In a case-control study comprising 717 type 2 diabetic patients and 518 glucose-tolerant subjects the most frequent variants did not show any difference in allele frequencies between the type 2 diabetic patients and the control subjects. However, in two genotype-quantitative trait correlation studies involving 206 glucose-tolerant offspring of type 2 diabetic patients and 359 young, healthy subjects the CDKN1C del171APVA variant associated with increased birth weight (P=0.05 and P=0.05). Furthermore, the same variant tended to be associated with decreased basal glucose oxidation among 16 genotypically discordant dizygotic twins (P=0.03). In a genotype-quantitative trait study involving 500 middle-aged glucose-tolerant subjects the CDK4 IVS2-31G-->A variant was associated with an increased waist circumference (P=0.03) and waist-to-hip ratio (P=0.02) and altered fasting plasma glucose (P=0.03). However, these later findings could not be replicated in additional studies. In conclusion, variants in CDKN1C may contribute to the inter-individual variation in birth weight.

Indexed as

Genetic VariationQuantitative Trait, HeritableAgedBirth WeightCase-Control StudiesCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p57Cyclin-Dependent KinasesDenmarkDiabetes Mellitus, Type 2DNA Mutational AnalysisFemaleGlucose Tolerance TestHumansInsulinMaleCDK4 protein, humanCDKN1C protein, humanCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p57Cyclin-Dependent KinasesInsulinNuclear ProteinsProto-Oncogene ProteinsRNA, Messenger

Identifiers

PMID15821902
OpenAlexW2162501947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.